Aquinox Pharmaceuticals, Inc. IPO Research Information

Aquinox Pharmaceuticals, Inc. IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Aquinox Pharmaceuticals, Inc., and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Aquinox Pharmaceuticals, Inc.	AQXP - NASDAQ	$10.00-$12.00	$11.00	$11.80	4.2 million	3/7/2014
Underwriter(s): Jefferies, Cowen & Co.
Co-Manager(s): Canaccord Genuity
Industry: Health Care
Filing(s): Filed 2014-01-28

Aquinox Pharmaceuticals, Inc. Quote & Chart - Click for current quote - AQXP

About Aquinox Pharmaceuticals, Inc. (adapted from Aquinox Pharmaceuticals, Inc. prospectus):
They are a clinical-stage pharmaceutical company discovering and developing novel drug candidates to treat inflammation and cancer.

This description is adapted from Aquinox AQXP prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as Aquinox AQXP "AQXP" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.